Jones Financial Companies
VIR icon

Jones Financial Companies’s Vir Biotechnology VIR Stock Holding History

Jones Financial Companies’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Sell
12,398
-394
-3% -$3.75K ﹤0.01% 2770
2026
Q1 		$107K Sell
12,792
-10,892
-46% -$86.8K ﹤0.01% 2639
2025
Q4 		$143K Buy
23,684
+5,450
+30% +$32.5K ﹤0.01% 2066
2025
Q3 		$100K Buy
18,234
+18,200
+53,529% +$93.1K ﹤0.01% 2089
2025
Q2 		$176 Buy
+34
New +$182 ﹤0.01% 3920

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jones Financial Companies's VIR Position: Q2 2026 in Review

Jones Financial Companies reduced its Vir Biotechnology (VIR) stake by 3.1% in Q2 2026, selling an estimated $3.75K and leaving 12,398 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

Jones Financial Companies first reported a position in VIR in Q2 2025 and has held it in 5 quarters since. The position peaked at $143K in Q4 2025. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Jones Financial Companies held 12,398 shares of Vir Biotechnology worth $124K as of Q2 2026.
  • Jones Financial Companies sold 394 Vir Biotechnology shares in Q2 2026, an estimated $3.75K.
  • Vir Biotechnology made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2770 holding.
  • Jones Financial Companies first reported a position in Vir Biotechnology in Q2 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Vir Biotechnology position peaked at $143K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.